Skip to main content

Table 2 Clinical results

From: Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device

  All patients
N = 189
eGFR≥45
N = 116
eGFR< 45
N = 73
p
Follow-up duration, years 310 188 122  
Cerebrovascular events, n (n/100py) 3 (1.0) 0 3 (2.5) 0.09
 • Stroke, n (n/100py) 2 0 2 (1.6) ns
 • TIA, n (n/100py) 1 0 1 (0.8) ns
Bleeding complications, n (n/100py) 5 (1.6) 0 5 (4.1) 0.06
 • Intracranial bleeding 0 0 0  
 • Gastrointestinal bleeding 1 (0.3) 0 1 (0.8) ns
 • Other bleeding 4 (1.3) 0 4 (3.3) ns
All-cause death, n (n/100py) 8 (2.6) 2 (1.1) 6 (4.9) ns
 • Cardiovascular death, n (n/100py) 6 (1.9) 2 (1.1) 4 (3.3) ns
Periprocedural complications
 • Pericardial effusion, n (%) 0 0 0  
 • DRT, n (%) 12 (6.5) 6 (3.2) 6 (8.2) ns
 • Other peri-procedural complications, n (%) 4 (2.1) 2 (1.7) 2 (2.7) ns
  1. 100py = one hundred patient years; TIA = transitory ischemic attack; DRT = device related thrombus